BNP Paribas Financial Markets’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,943
| Closed | -$244K | – | 3864 |
|
|
2019
Q3 | $244K | Buy |
12,943
+5,017
| +63% | +$94.6K | ﹤0.01% | 2045 |
|
|
2019
Q2 | $93.3K | Sell |
7,926
-5,615
| -41% | -$66.1K | ﹤0.01% | 2467 |
|
|
2019
Q1 | $185K | Buy |
13,541
+12,107
| +844% | +$165K | ﹤0.01% | 2184 |
|
|
2018
Q4 | $14.7K | Sell |
1,434
-1,968
| -58% | -$20.2K | ﹤0.01% | 2541 |
|
|
2018
Q3 | $56.6K | Sell |
3,402
-544
| -14% | -$9.06K | ﹤0.01% | 2340 |
|
|
2018
Q2 | $62.3K | Sell |
3,946
-9,646
| -71% | -$152K | ﹤0.01% | 2386 |
|
|
2018
Q1 | $173K | Buy |
13,592
+950
| +8% | +$12.1K | ﹤0.01% | 2324 |
|
|
2017
Q4 | $145K | Buy |
12,642
+5,899
| +87% | +$67.5K | ﹤0.01% | 2470 |
|
|
2017
Q3 | $82.6K | Buy |
6,743
+979
| +17% | +$12K | ﹤0.01% | 2489 |
|
|
2017
Q2 | $66K | Buy |
5,764
+4,891
| +560% | +$56K | ﹤0.01% | 2589 |
|
|
2017
Q1 | $18.2K | Sell |
873
-615
| -41% | -$12.8K | ﹤0.01% | 2544 |
|
|
2016
Q4 | $31K | Sell |
1,488
-2,356
| -61% | -$49K | ﹤0.01% | 2555 |
|
|
2016
Q3 | $126K | Buy |
3,844
+2,016
| +110% | +$66.1K | ﹤0.01% | 1989 |
|
|
2016
Q2 | $45.6K | Buy |
+1,828
| New | +$45.6K | ﹤0.01% | 2327 |
|
|
2016
Q1 | – | Sell |
-5,292
| Closed | -$175K | – | 3312 |
|
|
2015
Q4 | $175K | Buy |
5,292
+288
| +6% | +$9.51K | ﹤0.01% | 2028 |
|
|
2015
Q3 | $164K | Buy |
5,004
+3,292
| +192% | +$108K | ﹤0.01% | 2091 |
|
|
2015
Q2 | $90.7K | Buy |
1,712
+1,555
| +990% | +$82.4K | ﹤0.01% | 2132 |
|
|
2015
Q1 | $4.53K | Buy |
+157
| New | +$4.53K | ﹤0.01% | 3210 |
|
|
2014
Q4 | – | Sell |
-452
| Closed | -$5.73K | – | 3121 |
|
|
2014
Q3 | $5.73K | Buy |
+452
| New | +$5.73K | ﹤0.01% | 3269 |
|